Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04273061
Title Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity (CAPTIV-8)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors British Columbia Cancer Agency
Indications

lung cancer

breast cancer

urinary system cancer

sarcoma

Advanced Solid Tumor

female reproductive organ cancer

hepatobiliary system cancer

male reproductive organ cancer

gastrointestinal system cancer

pancreatic cancer

Therapies

Atezolizumab

Age Groups: adult | senior
Covered Countries CAN


No variant requirements are available.